https://www.omanhealthcarenews.com/article/905140755-upcoming-national-women-s-health-week-promoting-scalp-care-and-breathable-wig-solutions Oman Healthcare News en PressRelease 2026-04-11T14:00:00+00:00 Upcoming National Women’s Health Week: Promoting Scalp Care and Breathable Wig Solutions https://ml.globenewswire.com/media/OTI3YTJhY2UtNjYzMS00YWRhLWE4MTgtYTNmYTI2NWY1Yjg5LTEzMTk4MDUtMjAyNi0wNC0xMS1lbg==/tiny/Klaiyi-Hair.png https://www.omanhealthcarenews.com/article/905116581-biontech-and-dualitybio-s-antibody-drug-conjugate-trastuzumab-pamirtecan-demonstrated-clinically-meaningful-efficacy-in-patients-with-her2-expressing Oman Healthcare News en PressRelease 2026-04-11T11:00:00+00:00 BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.omanhealthcarenews.com/article/905116769-biontechs-und-dualitybios-antik-rper-wirkstoff-konjugat-kandidat-trastuzumab-pamirtecan-zeigte-klinisch-relevante-wirksamkeit-bei-patientinnen-mit Oman Healthcare News en PressRelease 2026-04-11T11:00:00+00:00 BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.omanhealthcarenews.com/article/905057231-neurosalt-under-investigation-what-the-2026-formulation-transparency-review-reveals-about-botanical-ingredients-dosage-disclosure-and-consumer Oman Healthcare News en PressRelease 2026-04-11T03:29:36+00:00 NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification https://zingfast.com/wp-content/uploads/2026/04/NeuroSalt-Reviews.jpg https://www.omanhealthcarenews.com/article/905024584-gentle-patches-claims-evaluated-2026-consumer-interest-rises-around-transdermal-wellness-patch-ingredients-product-lineup-and-policy-transparency Oman Healthcare News en PressRelease 2026-04-10T23:41:02+00:00 Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency https://zingfast.com/wp-content/uploads/2026/04/Gentle-Patches.jpg https://www.omanhealthcarenews.com/article/905007017-glo-spa-rkle-aesthetics-and-medical-spa-unveils-new-state-of-the-art-location-in-lubbock-texas Oman Healthcare News en PressRelease 2026-04-10T23:12:00+00:00 Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas https://pressranger.s3.us-west-1.amazonaws.com/3228357/Image-4-10-26-at-3.57%E2%80%AFPM.jpeg https://www.omanhealthcarenews.com/article/905007248-ivy-rx-claims-evaluated-2026-compounded-glp-1-telehealth-program-details-monthly-pricing-structure-clinician-access-model-and-patient-eligibility Oman Healthcare News en PressRelease 2026-04-10T22:54:36+00:00 IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information https://zingfast.com/wp-content/uploads/2026/04/Ivy-Rx.jpg https://www.omanhealthcarenews.com/article/904991023-readyrx-nad-rx-claims-evaluated-2026-update-highlights-changes-in-prescription-nad-nasal-spray-and-injection-access-pricing-and-telehealth Oman Healthcare News en PressRelease 2026-04-10T21:13:08+00:00 ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility https://zingfast.com/wp-content/uploads/2026/04/ReadyRx-NAD-Injection-ReadyRx-NAD-Nasal-Spray.jpg https://www.omanhealthcarenews.com/article/904990418-replimune-receives-complete-response-letter-from-the-fda-for-rp1-biologics-license-application-for-the-treatment-of-advanced-melanoma Oman Healthcare News en PressRelease 2026-04-10T21:02:32+00:00 Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma https://ml.globenewswire.com/media/Y2ExYzg2MzEtNjQxMi00MmIyLTg5NjQtM2JhYTU0YjVkOTAwLTExMjIxMDEtMjAyNi0wNC0xMC1lbg==/tiny/Replimune-Inc-.png https://www.omanhealthcarenews.com/article/904990052-pelthos-therapeutics-announces-cfo-transition Oman Healthcare News en PressRelease 2026-04-10T21:00:00+00:00 Pelthos Therapeutics Announces CFO Transition https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://www.omanhealthcarenews.com/article/904989897-vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Oman Healthcare News en PressRelease 2026-04-10T20:30:00+00:00 Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/b5c9081c-e6d9-44f7-abd0-0997a3c713f2/small/vera-thumbnail-jpg.jpg https://www.omanhealthcarenews.com/article/904990169-mesoblast-receives-ind-clearance-from-fda-to-directly-proceed-to-registrational-trial-for-approval-of-ryoncil-in-duchenne-muscular-dystrophy Oman Healthcare News en PressRelease 2026-04-10T20:09:52+00:00 Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://www.omanhealthcarenews.com/article/904989976-spyre-therapeutics-to-host-conference-call-to-report-spy001-part-a-induction-topline-results-from-skyline-trial-in-moderate-to-severe-ulcerative Oman Healthcare News en PressRelease 2026-04-10T20:05:00+00:00 Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026 https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.omanhealthcarenews.com/article/904990021-korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Oman Healthcare News en PressRelease 2026-04-10T20:05:00+00:00 Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.omanhealthcarenews.com/article/904989775-allogene-therapeutics-to-announce-interim-futility-analysis-data-from-its-pivotal-phase-2-alpha3-trial-with-cemacabtagene-ansegedleucel-cema-cel-in Oman Healthcare News en PressRelease 2026-04-10T20:02:00+00:00 Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026 https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.omanhealthcarenews.com/article/904973258-iradimed-corporation-to-participate-at-the-25th-annual-needham-virtual-healthcare-conference Oman Healthcare News en PressRelease 2026-04-10T19:14:57+00:00 IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/f353c867-559d-43a8-935c-ab497045e743/small/logo-gif.gif https://www.omanhealthcarenews.com/article/904971775-best-medical-alert-systems-2026-bay-alarm-medical-awarded-best-medical-alert-system Oman Healthcare News en PressRelease 2026-04-10T19:06:00+00:00 Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System https://pressranger.s3.us-west-1.amazonaws.com/3226873/bay-alarm-medical.png https://www.omanhealthcarenews.com/article/904973080-suja-life-announces-filing-of-registration-statement-for-proposed-initial-public-offering Oman Healthcare News en PressRelease 2026-04-10T18:52:29+00:00 Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering https://ml.globenewswire.com/media/9022887d-dd69-416f-9a4b-ce5e546d75e4/small/suja-life-horizontal-black-1-png.png https://www.omanhealthcarenews.com/article/904971348-matricis-ai-launches-first-u-s-clinical-pilot-of-endomai-for-ai-assisted-detection-of-endometriosis-with-simonmed Oman Healthcare News en PressRelease 2026-04-10T18:29:00+00:00 Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed https://ml.globenewswire.com/media/c74fe43e-1082-4594-9a53-fb3309961e2d/small/matricis-ai-logo.png https://www.omanhealthcarenews.com/article/904972086-novarad-to-showcase-surgical-augmented-reality-platform-visar-at-sir-2026 Oman Healthcare News en PressRelease 2026-04-10T17:32:18+00:00 Novarad to Showcase Surgical Augmented Reality Platform VisAR at SIR 2026 https://ml.globenewswire.com/media/MGZkMzk0ZWUtY2UxOS00MDNiLWI3MGYtNGFjN2M2OTQ3MmZkLTEyOTc0ODMtMjAyNi0wNC0xMC1lbg==/tiny/Novarad-Corporation.png https://www.omanhealthcarenews.com/article/904971600-the-ebony-canal-announces-global-birth-equity-tour-following-award-winning-season Oman Healthcare News en PressRelease 2026-04-10T17:10:57+00:00 The Ebony Canal Announces Global Birth Equity Tour Following Award-Winning Season https://ml.globenewswire.com/media/OWU1NmMyZTQtODMyMC00N2JkLWIwMjYtZTJlYmQyMzJjNjQzLTUwMDE0NTYwOC0yMDI2LTA0LTEwLWVu/tiny/The-Ebony-Canal.png https://www.omanhealthcarenews.com/article/904953706-humber-river-health-renames-wilson-site-hennick-humber-hospital-following-transformational-50-million-gift Oman Healthcare News en PressRelease 2026-04-10T15:00:00+00:00 Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift https://ml.globenewswire.com/media/44df2e20-b7f3-4ea6-ab08-40b257b45435/medium/hennick-humber-hospital.jpg